Sunshine Biopharma
Fort Lauderdale
About Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 4 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $24.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2025)
- Ticker: otcpink:SBFM
- Website: sunshinebiopharma.com
- Phone: 954-330-0684
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/sunshine-biopharma-107402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.